Real-time enrollment status for this glioblastoma, idh-wildtype clinical trial
Current Status
Recruiting
Checked: October 24, 2026 at 11:01 PM UTC
| NCT Number | NCT07452458 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma, IDH-Wildtype |
| Phase | PHASE3 |
| Target Enrollment | 398 participants |
| Active Locations | 54 sites in the US |
| Sponsor | NRG Oncology |
| Last Updated on CT.gov | September 10, 2026 (Sep 10, 2026) |
As of October 24, 2026: Clinical trial NCT07452458 is currently recruiting participants. This phase3 study for glioblastoma, idh-wildtype is actively seeking new participants at 54 locations across the United States. The study is sponsored by NRG Oncology. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07452458 is actively recruiting participants as of October 24, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 54 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07452458 was last updated Sep 10, 2026 (September 10, 2026). HelloStudys verifies this status automatically.